an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
Published 2 years ago • 94 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
3:27
the role of mrd in aml regulatory decision making
-
4:40
management of r/r myeloma and mrd assessment
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
5:30
commands: luspatercept vs epoetin alfa for anemia in esa-naive lr-mds
-
10:49
mayo clinic rochester
-
3:08
the treatment protocol for higher risk mds
-
6:00
icd-10-cm guideline review: chapter 6 diseases of the nervous system
-
2:57
novel targeted therapies for the treatment of bpdcn
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:30
recent advancements in bpdcn: diagnostic criteria, pathophysiology, and treatment
-
2:37
mrd 2020 update
-
0:55
the role of rna modifications in mds and aml
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
4:27
insights into a novel murine model being used to investigate the pathophysiology of icans
-
1:36
are novel therapeutics replacing asct?
-
1:37
mrd in myeloma